Externalized Reusable Permanent Pacemaker for Prolonged Temporary Cardiac Pacing in Critical Cardiac Care Units: An Observational Monocentric Retrospective Study
Abstract
:1. Introduction
2. Methods
2.1. Study Design
2.2. Study Population
2.3. Complications and Outcomes
2.4. Prolonged Temporary Cardiac Pacing
2.5. Ethics
2.6. Statistical Analysis
3. Results
3.1. Population
3.2. Indications and Devices
3.3. In-Hospital Outcomes
3.4. Six-Month Outcomes
3.5. Outcomes According to Indications
3.6. Outcomes According to the Occurrence of Complications
4. Discussion
4.1. Indications
4.2. Complications and Mortality
4.3. Outcomes
4.4. Limitations
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
AV | atrioventricular |
CIED | cardiac implantable electronic device |
PTCP | prolonged temporary cardiac pacing |
References
- Tjong, F.V.Y.; de Ruijter, U.W.; Beurskens, N.E.G.; Knops, R.E. A Comprehensive Scoping Review on Transvenous Temporary Pacing Therapy. Neth. Heart J. 2019, 27, 462–473. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Gammage, M.D. Temporary Cardiac Pacing. Heart 2000, 83, 715–720. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Glikson, M.; Nielsen, J.C.; Kronborg, M.B.; Michowitz, Y.; Auricchio, A.; Barbash, I.M.; Barrabés, J.A.; Boriani, G.; Braunschweig, F.; Brignole, M.; et al. 2021 ESC Guidelines on Cardiac Pacing and Cardiac Resynchronization Therapy: Developed by the Task Force on Cardiac Pacing and Cardiac Resynchronization Therapy of the European Society of Cardiology (ESC) With the Special Contribution of the European Heart Rhythm Association (EHRA). Eur. Heart J. 2022, 42, 3427–3520. [Google Scholar] [CrossRef]
- Cueni, T.A.; White, R.A.; Burkart, F. Pacemaker-Induced Ventricular Tachycardia in Patients with Acute Inferior Myocardial Infarction. Int. J. Cardiol. 1981, 1, 93–97. [Google Scholar] [CrossRef] [PubMed]
- Braun, M.U.; Rauwolf, T.; Bock, M.; Kappert, U.; Boscheri, A.; Schnabel, A.; Strasser, R.H. Percutaneous Lead Implantation Connected to an External Device in Stimulation-Dependent Patients with Systemic Infection—A Prospective and Controlled Study. Pacing Clin. Electrophysiol. 2006, 29, 875–879. [Google Scholar] [CrossRef] [PubMed]
- Lever, N. Prolonged Temporary Cardiac Pacing Using Subcutaneous Tunnelled Active-Fixation Permanent Pacing Leads. Heart 2003, 89, 209–210. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Rastan, A.J.; Doll, N.; Walther, T.; Wilhelmmohr, F. Pacemaker Dependent Patients with Device Infection—A Modified Approach. Eur. J. Cardiothorac. Surg. 2005, 27, 1116–1118. [Google Scholar] [CrossRef] [PubMed]
- Zei, P.C.; Eckart, R.E.; Epstein, L.M. Modified Temporary Cardiac Pacing Using Transvenous Active Fixation Leads and External Re-Sterilized Pulse Generators. J. Am. Coll. Cardiol. 2006, 47, 1487–1489. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Chihrin, S.M.; Mohammed, U.; Yee, R.; Gula, L.J.; Klein, G.J.; Skanes, A.C.; Krahn, A.D. Utility and Cost Effectiveness of Temporary Pacing Using Active Fixation Leads and an Externally Placed Reusable Permanent Pacemaker. Am. J. Cardiol. 2006, 98, 1613–1615. [Google Scholar] [CrossRef] [PubMed]
- Kawata, H.; Pretorius, V.; Phan, H.; Mulpuru, S.; Gadiyaram, V.; Patel, J.; Steltzner, D.; Krummen, D.; Feld, G.; Birgersdotter-Green, U. Utility and Safety of Temporary Pacing Using Active Fixation Leads and Externalized Re-Usable Permanent Pacemakers after Lead Extraction. Europace 2013, 15, 1287–1291. [Google Scholar] [CrossRef] [PubMed]
- Xiao, Z.; He, J.; Yang, D.; An, Y.; Li, X. Bridge Pacemaker with an Externalized Active Fixation Lead for Pacemaker-dependent Patients with Device Infection. Pacing Clin. Electrophysiol. 2022, 45, 761–767. [Google Scholar] [CrossRef] [PubMed]
- Pecha, S.; Aydin, M.A.; Yildirim, Y.; Sill, B.; Reiter, B.; Wilke, I.; Reichenspurner, H.; Treede, H. Transcutaneous Lead Implantation Connected to an Externalized Pacemaker in Patients with Implantable Cardiac Defibrillator/Pacemaker Infection and Pacemaker Dependency. Europace 2013, 15, 1205–1209. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Cipriano, R.; Gupta, A.; Subzposh, F.; McCaffrey, J.A.; Koman, E.; Fridman, D.; Saltzman, H.; Kutalek, S.P. Outcomes of Standard Permanent Active Fixation Leads for Temporary Pacing. JACC Clin. Electrophysiol. 2020, 6, 304–310. [Google Scholar] [CrossRef] [PubMed]
- Shah, N.H.; Shah, P.; Elsayed, H.; O’Callaghan, P.; Leong, F.T.; Yousef, Z. The Indications and Safety of Prolonged Temporary Pacing Using Active-fixation Leads and Externalized Pulse Generator. Pacing Clin. Electrophysiol. 2021, 44, 506–512. [Google Scholar] [CrossRef] [PubMed]
- Boriani, G.; Fauchier, L.; Aguinaga, L.; Beattie, J.M.; Blomstrom Lundqvist, C.; Cohen, A.; Dan, G.-A.; Genovesi, S.; Israel, C.; Joung, B.; et al. European Heart Rhythm Association (EHRA) Consensus Document on Management of Arrhythmias and Cardiac Electronic Devices in the Critically Ill and Post-Surgery Patient, Endorsed by Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), Cardiac Arrhythmia Society of Southern Africa (CASSA), and Latin American Heart Rhythm Society (LAHRS). EP Eur. 2019, 21, 7–8. [Google Scholar] [CrossRef]
- Perrot, B.; Cherrier, F.; Raivre, G. Significance of Supraventricular Arrhythmias Induced by Electrophysiologic Studies. Eur. Heart J. 1984, 5, 295–303. [Google Scholar] [CrossRef] [PubMed]
- Burri, H.; Starck, C.; Auricchio, A.; Biffi, M.; Burri, M.; D’Avila, A.; Deharo, J.-C.; Glikson, M.; Israel, C.; Lau, C.-P.; et al. EHRA Expert Consensus Statement and Practical Guide on Optimal Implantation Technique for Conventional Pacemakers and Implantable Cardioverter-Defibrillators: Endorsed by the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), and the Latin-American Heart Rhythm Society (LAHRS). EP Eur. 2021, 23, 983–1008. [Google Scholar] [CrossRef]
- Betts, T.R. Regional Survey of Temporary Transvenous Pacing Procedures and Complications. Postgrad. Med. J. 2003, 79, 463–465. [Google Scholar] [CrossRef] [PubMed] [Green Version]
- Metkus, T.S.; Schulman, S.P.; Marine, J.E.; Eid, S.M. Complications and Outcomes of Temporary Transvenous Pacing. Chest 2019, 155, 749–757. [Google Scholar] [CrossRef] [PubMed]
Characteristic | PTCP Population (n = 46) |
---|---|
Age (years) | 73 (62–78) * |
Female sex | 17 (37) |
Unit of admission | |
Critical care unit | 42 (91) |
Cardiology ward | 4 (9) |
Cardiovascular risk factors | |
Obesity | 14 (30) |
Diabetes mellitus | 12 (26) |
Arterial hypertension | 21 (46) |
Tobacco | 18 (39) |
Dyslipidemia | 15 (33) |
Peripheral artery disease | 6 (13) |
Immunosuppression | 0 (0) |
Respiratory insufficiency | 6 (13) |
Chronic kidney disease | 9 (20) |
Cancer | 0 (0) |
Prior heart disease | 29 (63) |
Ischemic heart disease | 14 (48) |
Dilated cardiomyopathy | 1 (3) |
Rhythm disorder | 17 (59) |
Valvular heart disease | 13 (45) |
Other | 2 (7) |
Medications at implantation | |
Vitamin K antagonists | 5 (11) |
Non-vitamin K antagonist oral anticoagulation | 3 (7) |
Aspirin | 27 (59) |
P2Y12 receptor inhibitor | 13 (28) |
Unfractionated heparin | 16 (35) |
Low molecular weight heparin | 15 (33) |
Betablocker | 5 (11) |
Non-dihydropyridine calcium channel blocker | 8 (17) |
Amiodarone | 9 (20) |
Other anti-arrhythmic drugs | 4 (9) |
Catecholamines | 19 (41) |
Antibiotics | 32 (70) |
Invasive mechanical ventilation at implantation | 11 (24) |
Renal replacement therapy at implantation | 9 (20) |
SAPS II at implantation | 37 (28–53) * |
Characteristic | |
---|---|
PTCP device type | |
Single-chamber VVI pacemaker | 46 (100) |
Vascular access a | |
Jugular vein | 23 (82) |
Subclavian vein | 5 (18) |
Delay from admission to PTCP implantation (days) | 4 (2–10) |
PTCP duration (days) | 9 (5–15) |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Beneyto, M.; Seguret, M.; Taranzano, M.; Mondoly, P.; Biendel, C.; Rollin, A.; Bounes, F.; Elbaz, M.; Maury, P.; Delmas, C. Externalized Reusable Permanent Pacemaker for Prolonged Temporary Cardiac Pacing in Critical Cardiac Care Units: An Observational Monocentric Retrospective Study. J. Clin. Med. 2022, 11, 7206. https://doi.org/10.3390/jcm11237206
Beneyto M, Seguret M, Taranzano M, Mondoly P, Biendel C, Rollin A, Bounes F, Elbaz M, Maury P, Delmas C. Externalized Reusable Permanent Pacemaker for Prolonged Temporary Cardiac Pacing in Critical Cardiac Care Units: An Observational Monocentric Retrospective Study. Journal of Clinical Medicine. 2022; 11(23):7206. https://doi.org/10.3390/jcm11237206
Chicago/Turabian StyleBeneyto, Maxime, Matthieu Seguret, Marine Taranzano, Pierre Mondoly, Caroline Biendel, Anne Rollin, Fanny Bounes, Meyer Elbaz, Philippe Maury, and Clément Delmas. 2022. "Externalized Reusable Permanent Pacemaker for Prolonged Temporary Cardiac Pacing in Critical Cardiac Care Units: An Observational Monocentric Retrospective Study" Journal of Clinical Medicine 11, no. 23: 7206. https://doi.org/10.3390/jcm11237206